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One of the few cell membrane antigens  for which  homology between species has 
been  established  is  Thy-1  of mouse  (1,  2)  and  rat  (3-5).  Even  between  species  as 
phylogenetically close as these, important differences in tissue distribution have been 
noted,  a  point  of considerable  interest  from  the  point  of view  of elucidating  the 
function  of the  molecule.  Thus,  whereas  in  both  species  it  is  found  in  large  and 
approximately equal amounts on brain and thymus, in the mouse it is absent  from 
bone marrow cells and found on all peripheral T  lymphocytes, although in the rat it 
is found on 30-40% of bone marrow cells and absent from peripheral T  lymphocytes. 
These results prompted us to study the tissue distribution  of the canine and human 
homologues of Thy- 1. 
Liver absorbed rabbit anti-brain xenosera assayed on thymus cells have been used 
as serological markers for mouse (2) and rat (4, 5) Thy-1. Similar assay systems can be 
established in other species, but it is clearly of fundamental  importance to establish 
that  the  molecules being  recognized  are  indeed  the  homologues of rat  and  mouse 
Thy-1. One approach for establishing homology is to demonstrate serological cross- 
reactivity with purified antigen from a well-studied reference species. In this paper we 
have  used  liver  absorbed  rabbit  anti-dog  and  human  brain  xenosera  assayed  on 
thymus ceils to study the tissue distribution  of canine and human Thy-1. We have 
taken  particular  care  (a)  to  establish  homology with  rat  Thy-1  by  demonstrating 
cross-reactivity with pure rat Thy-1  (kindly supplied by Dr. A. F.  Williams, Oxford 
[6]) and (b) to use quantitative absorption techniques with a large number of different 
tissues to detect  quantitative  as well as qualitative differences in tissue distribution. 
Our results demonstrate that canine and human Thy-1 show remarkable differences 
in  tissue distribution  when compared to the known  distribution  of both mouse and 
rat Thy- 1. 
Materials and Methods 
Tissue Homogenates.  Kidneys,  livers, hearts,  and brains of adult  dogs, kidneys and brain of 
a  l-d  old  dog,  and  livers  and  brains  of  10-20  wk  old  DA  rats  were  taken  from  freshly 
exsanguinated  animals.  Human  liver,  heart,  and  kidney  were  obtained  fresh  from  cadaver 
kidney  donors  and  a  piece of fresh  normal  human  brain  (cerebrum)  was  obtained  from  the 
Neurosurgery  Unit. The capsule of the organ to be homogenized was removed and the tissue 
minced  in  phosphate-buffered  saline  (PBS) 1 with  mechanically  driven  blades,  followed  by 
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mechanical homogenization with a  Teflon pestle and manual ground glass homogenization. 
Large particles were removed by centrifuging at 40 g for  1 min. The homogenate was then 
washed twice in PBS by spinning at 35,000 g for 20 min. The second pellet was resuspended in 
an equal volume of PBS,  aliquoted and frozen at -40°C. All procedures were carried out at 
4°C. 
Cell Suspensions.  All cell  suspensions used in this study were prepared fresh,  immediately 
before use. Thymus was taken from 6-8 wk old DA rats. 2-3 mo old pups, and as 1 cm  a biopsies 
from prepubertal patients at open heart surgery. All other tissues were from adults. Human 
spleen was  taken  from  splenectomy cases  for  trauma or  from  cadaver kidney donors, and 
human lymph nodes, usually cervical, were obtained from patients without systemic illness at 
surgery. Human bone marrow came from ribs removed at thoracotomy. Dog bone marrow also 
came from ribs and dog lymph nodes were mesenteric. Rat  lymph nodes were a  mixture of 
cervical and mesenteric. Contaminating erythrocytes (RBC)  were  removed by incubating in 
Tris-buffered ammonium chloride (7). Viability was assessed by trypan blue exclusion and was 
almost always better than 80%. Relatively pure suspensions of RBC were prepared by washing 
heparinized blood three times and removing supernate, buffy coat, and upper layer of RBC 
pellet after each wash. Cell counts were performed by using a Coulter Counter model DN. Pure 
suspensions of platelets were prepared by removing leukocytes and RBC from blood by two 
sequential spins at  200 g for 20 rain. Platelets were washed twice  and counted under phase 
contrast microscopy on a hemocytometer. 
Antisera 
RABBIT ANTI-DOG  AND HUMAN BRAIN SERA.  Rabbit anti-brain  sera were raised by immunizing 
three New Zealand white rabbits with dog brain homogenate and three with human brain 
homogenate. The initial injection consisted of 1 ml of brain homogenate emulsified in an equal 
volume of Freund's complete adjuvant, and was given intramuscularly to both thighs. Boosts 
of 1 ml of homogenate in Freund's incomplete adjuvant were also given intramuscularly to the 
thighs at 2, 4, and 6 wk after the initial injection. A further boost of 1 ml of homogenate in PBS 
intraperitoneally was given at week  7, and the animals were bled three times during weeks 8 
and 9. The three bleeds from any one animal were pooled. 
IMMUNOADSORBENT PURIFIED  GOAT F(ABt)2  ANTI-RABBIT  F(ABt)2  (GAR),  Rabbit  F(ab')2 was 
prepared by precipitating rabbit immunoglobulins  from serum three times with  18% wt/vol 
Na2SO4 at room temperature, followed by pepsin degradation at an enzyme/substrate ratio of 
4% for 20 h at 37°C in sodium acetate buffer at pH 4.5, and finally by gel filtration through G- 
200  (Pharmacia,  Sweden).  The  F(ab')2 was  pure  as  assessed  by  SDS  polyacrylamide gel 
electrophoresis (8). Approximately 100 mg of rabbit F(ab')2 was coupled to  10 ml of CNBr- 
activated Sepharose (Pharmacia, Sweden) essentially as described by the manufacturers. Heat 
inactivated and uhracentrifuged goat antiserum to this F(ab')2 preparation was passed through 
the column until it was saturated, the column was washed, and the adsorbed antibody eluted 
with I molar propionic acid. The eluted fractions were immediately neutralized with 2 M Tris, 
and the eluted antibody pepsin degraded as above, except that a pH of 4.1 was necessary for 
complete degradation. After pepsin degradation the antibody was passed through G-200. GAR 
was iodinated by using the chloramine T  method, and labeled with fluorescein isothiocyanate 
by using bicarbonate buffer, pH 9.5, for 3 h at room temperature. 
IMMUNOADSORBENT  PURIFIED  RABBIT F(AB¢)2 ANTI-DOG F(AB')2  (RAD).  This  was  prepared 
essentially as  had  been  described  for  GAR,  except  that  dog  immunoglobulin was  pepsin 
degraded at a pH of 4.1. 
Quantitative Absorption Analysis.  This was essentially as described by Morris and Williams (5). 
Cell suspensions, and tissue and serum dilutions, were in 0.5% bovine serum albumin (BSA) in 
PBS. All procedures were at 4°C or on ice. 
Initial titrations of the sera were performed to choose a dilution which represented conditions 
of target antigen excess in the assay system. For the titration, 25-/~1 aliquots of doubling dilutions 
of the  antisera were  transferred  in duplicate to  LP3  tubes  (Luckham  Ltd.,  Labro Works, 
Victoria Gardens, Burgess  Hill, Sussex)  and to each tube was added 25 p,1 of thymus cells at 
10S/ml as targets. This was incubated for  l  h on ice, and the cells were then washed twice in 
0.1% BSA/PBS. To the cell button of the second wash was added  100/~l of GAR at 25 p,g/ml 
with a trace (~400,000 cpm/assay) of 12~I-labeled GAR. The cells were incubated again for  1 
h on ice, washed twice, and the cell-bound radioactivity measured. With the assay, the amount 578  TISSUE DISTRIBUTION OF CANINE AND  HUMAN THY-1 
of GAR bound per assay is directly proportional to the amount of first  antibody bound, and 
the results of the assay are expressed as ng GAR bound per assay, which can be calculated 
easily. 
For the absorptions, equal vol (80 #1) of antiserum at the appropriate dilution and tripling 
dilutions of the absorbing cell suspension or tissue  homogenate were incubated for 1 h on ice. 
Absorbing tissue  was removed by centrifugation,  and  the supernate  frozen at  -40°C  until 
assayed. When all absorptions for a particular analysis were complete, supernates were thawed, 
spun at 6,000 g for 5 min, and 25-/~1 aliquots were assayed in duplicate as above. 
The starting concentration of cells for absorptions was 109/ml, except for RBC and platelets 
which were  used  at  3  ×  109 ml  and  6  ×  109/ml,  respectively,  Homogenates were used  at 
starting concentrations as prepared  above (i.e., =50% solid  tissue)  which corresponded to a 
protein concentration of 25-35 mg/ml as assayed by the method of Lowry et  al.  (9). Lymph 
node lymphocytes at  109/ml  also had protein concentration of =25 mg/ml. Cell suspensions 
and  tissue  homogenates were aligned  on  the  basis  of protein  content,  i.e. 109 cells/ml  was 
equivalent to 25 mg protein/ml, the rationale for which has been discussed  previously (10). 
When rat thymus cells were used as targets, the GAR was used under trace conditions (0.1 
#g/ml and =300,000 cpm/assay) to increase sensitivity (5). 
Fluorescence-Activated Cell Sorter.  Cells for analysis on the cell sorter were prepared exactly as 
in  the binding assay mentioned  in  the previous section, except  that  (a)  the rabbit  anti-dog 
brain  serum was pepsin  degraded  to F(ab')2 to prevent  binding to Fc receptors,  and  (b)  the 
second antibody consisted of 50 #1 of fluorescein-labeled GAR at 25/~g/ml. 
Results 
Canine  Thy-1.  The  three  rabbit  anti-dog  brain  sera  were screened  for the  broad 
tissue  distribution  of the brain-thymus specificities  present,  by absorbing with  liver, 
heart, kidney, and brain and assaying on thymus cells. All three gave the same picture, 
with liver and heart giving absorption plateau  after removing =50% of the antibody, 
indicating  the  presence  of brain-thymus  specificities  of relatively  restricted  tissue 
distribution.  All subsequent  analyses were performed on the one batch of serum after 
it had been absorbed with liver to the absorption plateau. 
TISSUE DISTRIBUTION  OF THE PUTATIVE  CANINE  HOMOLOGUE  OF THY-I.  In this section, 
we describe the tissue distribution of the antigens recognized by liver absorbed rabbit 
anti-dog  brain  serum  assayed  on  dog thymus  cells.  The  entire  absorption  analyses 
were done twice on separate occasions with very similar results, and the quantitations 
quoted represent  the mean of the two experiments. 
In  Fig.  1  are  given  the  results  for  absorptions  by  the  tissue  homogenates  and 
thymus.  It can be seen  that  brain  gave very strong absorption,  while  the absorptive 
capacity of thymus was only 8% that of brain. The absorptive capacity of kidney was 
equal to that of thymus, although liver and heart had very little absorptive capacity. 
It should be noted  that  the  absorption  by kidney could not  be nonspecific because, 
like liver, heart, and brain, it gave only poor absorption of rabbit anti-clog thymocyte 
2  sera. 
Fig.  2 gives the results for absorptions with various cell suspensions.  It can be seen 
that  both  lymph  node  and  spleen  could  absorb  out  the  antibody,  their  absorptive 
capacities compared with thymus being 37 and  14%, respectively. Bone marrow gave 
some absorption,  its absorptive capacity compared to thymus being 7%. The absorp- 
tive capacities of lymph node spleen and bone marrow compared to brain were 3,  1, 
and  0.5%,  respectively.  Platelets,  RBC,  and  normal  serum  gave  no  absorption.  In 
another experiment  bone marrow, spleen, and lymph node were shown to be capable 
of absorbing out the antibody" down to background levels. 
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FIG.  1.  Tissue distribution of canine Thy-1. Liver absorbed rabbit anti-dog brain serum at  1/10 
absorbed with the dog tissues indicated and assayed on dog thymus cells. A, thymus; ,6, brain; r-I 
kidney; O, liver; 0, heart, 
If the assays shown in Figs.  1 and 2 are detecting the canine homologue of Thy-1, 
then canine Thy- 1 is present primarily on the brain, and to a lesser extent on thymus, 
kidney, and the peripheral  lymphoid tissues. 
ESTABLISHMENT OF HOMOLOGY  WITH RAT THY-I.  Arndt et al.  (1 1) have shown that 
rabbit  anti-human  brain  sera  are  cytotoxic  for  mouse  and  rat  thymus  cells.  This 
prompted  us  to  set  up  binding  assays  of the  liver  absorbed  rabbit  anti-dog  brain" 
serum  on  rat  thymus  cells,  to  enable  us  to  study  the  component  of the  serum 
recognizing specificities shared between dog brain and rat thymus. We wished to show 
(a)  that  this  component  represented  the  dog-rat  cross-reactive  component  of Thy-1 
and  (b) that this component reacted with the same antigen(s)  as the full complement 
of antibodies studied  in Figs.  1 and 2. 
Fig. 3 gives the results of absorptions with rat tissues, to give the tissue distribution 
in the rat of the cross-reactive component, and also of absorptions with pure rat Thy- 
1 (kindly supplied  by Dr.  A.  F. Williams,  Oxford  [6]).  It can be seen  that  rat  brain 
and thymus gave excellent  absorption,  although rat  liver and lymph node absorbed 
poorly or not at  all.  The discrepancy between  thymus and lymph node is especially 
striking,  and the pattern  corresponds precisely to what one would expect if the assay 580  TISSUE  DISTRIBUTION  OF  CANINE  AND  HUMAN  THY-I 
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FIG.  2.  Tissue distribution of canine Thy-1. Liver absorbed rabbit  anti-dog brain serum at  1/10 
absorbed with  the dog tissues indicated  and assayed on dog thymus cells. A, thymus; m, lymph 
node; O, spleen;  ×, bone marrow; I-1, erythroeytes; ©, platelets; A  normal serum. 
were detecting Thy-1 (4, 5). This is confirmed by the absorption with small quantities 
of pure rat  Thy-1. The slope of the  absorption  curve is less  steep with  pure Thy-1 
probably because the soluble molecule absorbs low affinity antibodies less efficiently 
than Thy-1 in matrix form on the membrane of whole cells. 
The results  presented  in  Fig.  3  establish  that  a  component  of the liver absorbed 
anti-brain  serum  is  detecting  the  canine  homologue  of Thy-1,  but  this  does  not 
necessarily mean  that  all  the  antibodies  assayed in  Figs.  1 and  2  are also directed 
against Thy-1. To establish this point, we looked at the tissue distribution of the cross- 
reactive component by using dog tissues.  The results  are given in  Fig.  4, and show 
that the tissue distribution  in the dog of the cross-reactive component is the same as 
the tissue distribution of the full complement of specificities recognized in Figs.  1 and 
2. This strongly suggests that the assays in Figs.  1-4 are recognizing the same molecule. 
In Figs.  1 and 2 the dog-specific as well as the dog-rat cross-reactive components of 
Thy-1 are being recognized, although only the latter component is being recognized 
in Figs. 3 and 4. 
CANINE THY-I ON PERIPHERAL  T LYMPHOCYTES.  Thy-1 is a  marker for peripheral T 
lymphocytes in the mouse (1) but not the rat (4). To see what the situation was in the 
dog, the distribution  of canine Thy-1  on lymph node lymphocytes was analyzed by 
using  the  fluorescence-activated cell  sorter  (Materials  and  Methods).  Lymph node 30.0 
ROSEMARIE DALCHAU  AND JOHN W.  FABRE  581 
ng  PURE  RAT  THY-I  PER ASSAY 
102  101  10  °  ]0  -I 
t  !  !  I 
ABSORBING  TISSUE  (~g  PROTEIN  PER  ASSAY) 
102  I01  1O  ° 
25.0 
20.0 
CQm  BOUND  X 
10 -3 
15.0 
10.0 
5,0 
L  I  I  I  | 
0  10 7  10 6  10 5  10 4 
ABSORBING  CELLS  PER  ASSAY 
FIG.  3.  Dog-rat cross-reactive component of Thy-1 on rat tissues. Liver absorbed rabbit anti-dog 
brain serum at  1/10 absorbed with the rat tissues indicated and assayed on rat thymus cells. A, rat 
thymus; i, rat lymph node; *, pure rat Thy-l; A, rat brain; C), rat liver. 
lymphocytes were incubated with (a)  liver absorbed, pepsin degraded rabbit anti-dog 
brain  serum  at  1/10  (b)  immunoadsorbent  purified  RAD  at  50  gg/ml  to  label  B 
lymphocytes;  (c)  both  (a)  and  (b)  together,  to  give the  same  final  concentration  of 
both  antisera;  and  (d)  0.5%  BSA/PBS.  The  fluorescence profiles  for  (a)  and  (c)  are 
given  in  Fig.  5.  It  can  be  seen  that  with  the  liver  absorbed  anti-brain  serum  there 
were  two  distinct  subpopulations,  with  the  dull  peak  (on  the  left  of the  Figure) 
containing 33% of the cells, and  the bright  peak 67%. The RAD labeled  36% of the 
cells  (Figure  not  shown).  These results were suggestive that  the liver absorbed  anti- 
brain serum was labeling the T  lymphocytes but not the B lymphocytes, and to prove 
this point  the mixing experiment  (c) was performed.  It can be seen that the addition 
of RAD to the liver absorbed  anti-brain  serum  resulted  in the disappearance  of the 
dull peak, showing that  this peak contained the B  lymphocytes. Thus canine Thy-1, 
like mouse Thy-1, is found on all peripheral  T  lymphocytes. 
CANINE  THY-I  ON THYMOCYTES.  Studies  with  the fluorescence-activated  cell sorter 
were also performed  by using thymus cells  (Figure not shown).  In four experiments, 
95-100% of thymocytes were brightly stained  by using the liver absorbed  anti-brain 
serum,  suggesting that  all,  or virtually  all,  dog thymocytes were positive  for Thy-1. 582 
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FIG.  4.  Dog-rat cross-reactive component of Thy-1 on dog tissues.  Liver absorbed rabbit anti-dog 
brain serum at  1/10 absorbed with the dog tissues indicated  and assayed on  rat  thymus cells, ml 
lymph node; A, brain; I-3, kidney; O, liver. 
FIc;.  5.  Canine  Thy-I  on  peripheral  T  lymphocytes.  Fluorescence  profile  of dog  lymph  node 
lymphocytes incubated  with  (a)  liver absorbed, pepsin degraded  rabbit  anti-dog brain serum at 
1/10  and  (c)  anti-brain  serum as  in  (a)  plus immunoadsorbent purified  rabbit  F(ab')2 anti-dog 
F(ab')2 at 50 ~g/ml. The ordinate is a log scale for cell number and the abscissa gives the degree of 
fluorescence in arbitrary units. ng  GAR 
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Fla.  6.  Canine Thy-1  on  neonatal  tissues. Liver absorbed  rabbit  anti-dog brain serum at  1/10 
absorbed  with  the  dog  tissues  indicated  and  assayed  on  dog  thymus cells.  •  A,  thymus; 
•  ....  •,  neonatal  thymus; A  A  brain;  A---A,  neonatal  brain;  []  '•,  kidney; {[L--Q, 
noenatal kidney. 
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CANINE THY-I ON NEONATAL TISSUES.  Neonatal rats (4)  and mice (l)  have normal 
amounts of Thy-1 on thymus but only small amounts on brain, and it was of interest 
to check this point with respect to canine Thy-1. Results of absorptions with thymus, 
brain, and kidney from neonatal  and adult  dogs are given in  Fig.  6.  It can be seen 
that neonatal thymus and kidney have approximately as much Thy-1 as adult tissues. 
Neonatal brain, however, has only 14% as much Thy-1 as adult brain, indicating that 
brain Thy-1 develops mainly in postnatal life in the dog. 
Human Thy-1.  The three rabbit anti-human brain sera were screened for the broad 
tissue distribution  of the brain-thymus specificities present, by absorbing with liver, 
heart, kidney, and brain and assaying on thymus cells.  In all three cases, liver, heart, 
and kidney could absorb out all the brain-thymus specificities. This picture is quite 
different  from that  in the dog and from the well known situation  in the rat  (4)  and 
suggests that the anti-human brain sera do not recognize brain-thymus specificities of 
restricted tissue distribution. 
There are three broad interpretations of this fnding in terms of a human homologue 584 
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FIG.  7.  Human-rat  cross-reactive  component  of Thy-1.  Rat  liver  absorbed  rabbit  anti-human 
brain serum at  a  1/8 dilution absorbed with the rat tissues indicated  and assayed on rat  thymus 
cells.  A  rat thymus; i,  rat lymph node;  *, pure rat Thy-1; A, rat brain; O, rat liver. 
of Thy-1. First,  it  is possible that our antisera do not contain anti-Thy-I antibodies, 
because Thy-I  might  not  be  immunodominant on human brain,  or might even be 
absent from human brain. Second, the antisera might contain anti-Thy-1 antibodies, 
and Thy-1 in man is more broadly distributed than in the rodent or dog. Finally, it 
is possible that Thy-1  is absent  from human thymus, in which case any anti-Thy-1 
antibodies would not be assayed for when human thymocyte targets are used. 
ASSAYS  FOR  THE  HUMAN-RAT  CROSS-REACTIVE  COMPONENT  OF THY-I.  We  tested  our 
anti-human brain sera for binding to rat thymus cells  and found that as in the dog, 
this system enabled us to study antigens cross-reactive between human brain and rat 
thymus cells.  One batch of serum was used for all the experiments, and it was given 
a preliminary absorption with rat liver before the subsequent assays were performed. 
To establish that the rat liver absorbed rabbit anti-human brain serum assayed on 
rat thymus cells was detecting the human-rat cross-reactive component of Thy-1, we 
performed experiments similar to those described in Fig. 3 for the dog. The results are 
given  in  Fig.  7,  and  show  that  the  cross-reactive  component  is  present  in  equal 
amounts on rat brain and rat thymus, in negligible amounts on rat liver and lymph ROSEMARIE  DALCHAU AND JOHN  W.  FABRE 
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FIG. 8.  Tissue distribution of human Thy- 1. Rat liver absorbed rabbit anti-human brain serum at 
a  1/8 dilution absorbed with the human tissues indicated and assayed on rat thymus cells. A, brain; 
A, thymus; I,  lymph node; 0,  spleen;  ×, bone marrow; I-'1, erythrocytes;  0,  platelets;  *, normal 
serum. 
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node lymphocytes, and that pure rat Thy-1  in small quantities could remove --75% 
of the antibodies with the absorption curve still on a downward slope. As previously 
explained, these cross-reactivity studies establish that our assay system is detecting the 
human-rat cross-reactive component of Thy-1.  It follows, therefore, that our sera do 
contain antibodies to the human homologue of Thy-1. 
Tissue  DISTRmUTION Or HUMAN THY-t.  In  Figs.  8  and  9  are  given  the  results  of 
quantitative absorptions with 11 different human tissues. The analysis was performed 
twice on separate occasions with virtually identical results. It is clear from Fig. 8 that 
brain contains large amounts of Thy-1  (the inhibition curve is similar to that seen in 
dog and rat systems) but that thymus, lymph node, spleen, bone marrow, erythrocytes, 
platelets,  and serum contain no detectable Thy-1.  Since the assay system is sensitive 
enough to detect amounts of Thy-1  of the order of 0.5%  or less compared with brain, 
and since the tissues mentioned gave no hint of absorption, a conservative estimate of 
the  maximum  amount  of Thy-1  that  could  be  present  on  them  would  be  0.2% 
compared  with  brain.  It  is  reasonable,  therefore,  to say  that  Thy-1  is  absent  from 
these tissues.  Fig.  9  shows that Thy-1  is absent  from liver and heart, but present on 18 
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FIG.  9.  Tissue distribution of human Thy-1. Rat liver absorbed rabbit anti-human brain serum at 
a  1/8  dilution  absorbed  with  the  human  tissues  indicated  and  assayed  on  rat  thymus  cells. 
Designation X  2 indicates preabsorption with the pellet after centrifugation of an equal volume of 
the tissue indicated. /X  A, brain; A---A, brain  x  2; []  V-I, kidney; [B---V], kidney X 2; 
O, liver; 0, heart. 
human kidney, the amount being ~5% compared with brain. This is similar to our 
findings in the dog. There is no question of the absorption by kidney being nonspecific 
because, like liver, brain, and heart, it gave only weak absorption of anti-thymocyte 
2  sera. 
CROSS-REACTIVITY STUDIES.  Morris  et  al.  (12)  and  Thiele  and  Stark  (13)  have 
studied  the serological cross-reactivity between mouse and rat Thy-1. These authors 
have shown that rabbit antibodies to rat Thy- 1 fall into two main groups, one directed 
at  a  rat-specific component, and one at  a  rat-mouse cross-reactive component.  We 
were interested to examine the extent of serological cross-reactivity between the Thy- 
1 molecules of the relatively distant species studied  in this paper, because this might 
give an  idea of the extent  to which  Thy-1  has been conserved during evolution.  It 
would also be interesting to relate serological cross-reactivity to subsequent structural 
studies. 
The results given in Fig.  10 show that human brain can absorb out a  substantial 
component of the rabbit antibodies against dog Thy-1, indicating a substantial degree 
of serological  cross-reactivity  between  dog  and  human  Thy-1.  Rabbit  antibodies 
against  dog  Thy-1  are  clearly  divisible  into  those  directed  at  a  dog-human  cross- ROSEMARIE DALCHAU AND JOHN W.  FABRE  587 
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Fro. 10.  Cross-reactivity  among rat, dog, and human Thy-1. Liver absorbed rabbit anti-dog brain 
serum at 1/10 absorbed with the tissues indicated and assayed  on dog thymus cells. A  A, dog 
brain;  A----ZX, human  brain; A---A, rat  brain; 0  O,  dog liver; 0---'----0, human  liver; 
0----0, rat liver. 
reactive component (that part absorbed by human brain) and a dog-specific compo- 
nent.  Rat  brain  gave only slight  absorption, showing that  dog and rat Thy-1  show 
only a slight degree of cross-reactivity. 
Fig.  11  shows  that  human  brain  can  absorb  out  all  the  dog-rat  cross-reactive 
component. The converse experiment showed that dog brain could absorb out all the 
human-rat cross-reactive component, the figure (not shown) being virtually identical 
to  Fig.  l l.  Thus  the  dog-rat  and  human-rat  components  are  identical  and  this 
indicates  that  a  part  of  the  Thy-1  molecule  has  been  highly  conserved  during 
evolution. 
Discussion 
This  study  shows  that  the  tissue  distribution  of Thy-1  varies  remarkably  from 
species to species. A summary of the data in the mouse, rat, dog and man is given in 
Table I. The only tissue to give consistent results in all species studied to date is brain, 
which  in  all cases has expressed large amounts of Thy-1. The absorption curves for 
the  cross-reactive components  (Fig.  11)  suggest  that  the  amount  of Thy-1  on  the 
brains  of the  different  species  is  approximately  the  same.  Thymus  contains  large 
amounts of Thy-1  in the rat and mouse, small amounts of Thy-1 in the dog, but no 588  TISSUE  DISTRIBUTION  OF  CANINE  AND  HUMAN THY-l 
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FIG.  11.  Dog-rat cross-reactive component of Thy-1  on human brain. Liver absorbed rabbit anti- 
dog brain  serum at  1/10  absorbed with  the tissues  indicated and  assayed  on  rat  thymus cells. 
A  A,  dog brain;  A----A, human  brain;  a--  -A, rat  brain;  ©  O,  dog liver;  O-'---O, 
human liver; O---O, rat liver. 
detectable Thy-1 in man. Kidney has significant amounts of Thy-1 in dog and man, 
but  does not carry Thy-1  in  mouse or rat.  In one study (5)  rat kidney was noted in 
passing to have very slight absorptive capacity for Thy-1, ~0.5% compared with rat 
brain)  but  this  was  not  considered  significant.  Peripheral  T  lymphocytes of mouse 
and dog, but not rat and man, carry Thy-1. Bone marrow cells of the rat and dog, but 
not mouse or man, carry Thy-1. 
With such unexpected tissue distributions for canine and human Thy-1, it is clear 
that the establishment  of homology is crucial to the whole study. The use of the rat 
as  a  reference  species,  and  pure  rat  Thy-1  for  cross-reactivity  studies  establishes 
homology  in  our  assay  systems.  In  addition  we  have just  completed  biochemical 
studies  with  deoxycholate  solubilized  brain  (J.  L.  McKenzie  and  J.  W.  Fabre, 
unpublished  observations) which show that the liver absorbed rabbit anti-dog brain 
serum assayed on dog thymus cells and the liver absorbed rabbit anti-human  brain 
serum assayed on rat thymus cells each detects on dog and human brain, respectively, 
a  single  specificity which  behaves in  every respect  (molecular weight  on  SDS  gels, 
Stokes radius, lectin affinity chromotography) like rat Thy-1  (6). 
Thus, not only is Thy-1 present on functionally diverse tissues within a species, but 
its  presence  on  any  given  tissue  varies with  the  species studied.  The  most  striking ROSEMARIE  DALCHAU  AND JOHN  W,  FABRE 
TABLE  I 
Summary of Tissue Distribution of Thy-1 in the Mouse, Rat, Dog, and Man* 
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Mouse  Rat  Dog  Man 
Brain  +++  +++  +++  +++ 
Kidney  0  0  +  + 
Liver, heart  0  0  0  0 
Thymus  + + +  + + +  +  0 
Lymph node  + +  0  +  0 
Spleen  + +  +  +  0 
Bone marrow  0  +  +  0 
RBC, platelets, serum  0  0  0  0 
* Results for mouse and rat taken from (1) and (4),  respectively. 
expression  of  this  phenomenon  is  thymus.  Thy-1  is  a  major  component  of  the 
thymocyte membrane of mouse and rat, amounting to ~600,000  molecules per cell 
(5)  but is not detectable on human thymus (the upper limit, given the sensitivity of 
the assay, being 1,000  molecules of Thy- 1 per human thymocyte). Whatever function 
Thy-1  performs on  rat  thymocytes has  clearly been  lost  or  taken  over by another 
molecule on human thymocytes. An interesting corollary of this finding is that even 
major membrane molecules will not necessarily have homologues in other mammalian 
species. 
One possibility that should be considered is that the unusual tissue distribution  of 
Thy-1 within and between species is an artifact of assaying for antigenicity.  Barclay 
et  al.  (14)  have shown  that  rat  Thy-1  is  a  glycoprotein with  a  high  carbohydrate 
content,  and  that  the  composition  of the  carbohydrate  differs  between  brain  and 
thymus  Thy-1.  The  antigenicity,  however,  resides  in  the  polypeptide  chain.  It  is 
possible that quantitative or qualitative differences in glycosylation of the polypeptide 
chain  could  affect antigenicity  either by steric hindrance  or by changes  in  tertiary 
structure.  However, the simplest and most likely hypothesis is that  antigenicity  is a 
true reflection of the tissue distribution  of the molecule. 
Probably because Thy-1 of rat and mouse is found in large amounts on brain and 
thymus, attempts have been  made to define brain-thymus antigens  in  the  dog and 
man.  In  the  human  studies,  xenosera  to  fetal brain  were shown  not  to react  with 
thymus cells  (15-17)  though  in  two studies  they did react with  a  subpopulation of 
peripheral T  lymphocytes (5, 6). Of three studies with xenosera to adult human brain, 
two,  (18,  19)  could not  detect  any activity against  thymus cells, while in one study 
(20)  some  of  the  sera  analyzed  reacted  with  all  thymocytes  and  peripheral  T 
lymphocytes. The previous study in the dog (19) showed that appropriately absorbed 
rabbit anti-dog brain sera were cytotoxic for 100% of thymocytes, 50% of lymph node 
lymphocytes,  and  25%  of  bone  marrow  cells,  and  moreover  that  the  specificity 
examined was present in low amounts on neonatal brain. 
In none of the above studies were attempts made to look at the tissue distribution 
of the  antigens  recognized.  In  addition,  where  positive interactions  were  obtained 
between brain and peripheral T  lymphocytes (15,  16) and between brain and thymus 
in man (20)  and dog (19), no attempts were made to establish homology with rodent 
systems. This is especially important because a brain-thymus-peripheral T lymphocyte 
antigen  quite  distinct  from  Thy-1  has  recently  been  described  in  the  rat  (21). 
Moreover, in  the absence of prior knowledge as to the immunodominance of Thy-1 590  TISSUE DISTRIBUTION OF CANINE  AND  HUMAN  THY-1 
on human brain the negative reports for brain thymus cross-reactivity are difficult to 
interpret  with respect to Thy-1. 
Thy-1  has  been  detected  in  the  rodent  on  skin  (22)  fibroblasts  (23),  mammary 
tumors  (24), and striated  muscle in culture  (25). Whether or not canine and human 
Thy-1 are on these tissues remains to be seen. Antigens which are primarily on brain 
and  to a  lesser extent  on kidney have been described  in the  mouse  (26-29)  and  rat 
(30), but  in all cases these antigens  have been absent  from thymus. The specificities 
examined  in  this  paper  are  clearly present  in large  amounts on rat  thymus  (Figs.  3 
and  7)  and are therefore not related  to the above-mentioned brain-kidney  antigens. 
Thy-1  was so named  because  it  is a  major component of rat  and  mouse thymus. 
The absence  of Thy-1  from human  thymus therefore  raises  interesting  problems  of 
nomenclature. 
Summary 
The tissue distribution of the canine and human homologues of Thy-1 were studied 
using quantitative  absorption analyses of hver absorbed anti-brain  xenosera assayed 
on  thymus  cells.  Cross-reactivity  studies  with  pure  rat  Thy-1  established  that  the 
assays were detecting the homologues of rat Thy-1. The results showed that the tissue 
distribution  of Thy-1 varies remarkably between species. Canine Thy-1 was found in 
large  amounts  only  on  adult  brain.  It  was  present  in  much  smaller  amounts  on 
thymus  (8% compared with brain),  and was also found on lymph node, spleen  and 
bone marrow (3,  1, and 0.5%, respectively, compared with brain). Surprisingly, it was 
found on kidney in amounts equal to that on thymus. Studies with the fluorescence- 
activated cell sorter established  that canine Thy-1 was present on all thymocytes and 
peripheral  T  lymphocytes. Neonatal  thymus and  kidney had  adult  levels of Thy-1, 
but only small amounts of Thy-1 were present on neonatal brain.  In man, brain was 
again  the only tissue  to contain  large amounts of Thy-1. Surprisingly,  it was absent 
from human thymus, and present  on human kidney in amounts roughly equivalent 
to that seen in the dog. It was absent  from spleen,  lymph node, bone marrow, liver, 
heart, erythrocytes, platelets, and serum. Cross-reactivity studies showed that dog and 
human  Thy-1  showed extensive serological cross-reaction,  and  that  the  dog-rat and 
human-rat  cross-reactive components were identical. 
Received  for publication 26 October 1978. 
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